MariMed to be Featured at Canaccord Genuity U.S. Cannabis Symposium
Fireman, CEO of 2018 Top Performing Cannabis Stock, will share insight on MariMed, U.S. cannabis market opportunity
NEWTON, MA and TORONTO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- MariMed Inc. (OTCQB: MRMD) CEO Robert Fireman will be a featured presenter at Canaccord Genuity’s US Canada Cannabis Symposium at the Sheraton Centre Toronto Hotel in Toronto, on Thursday, October 18 at 1:10 pm (track one).
As founder and CEO of MariMed Inc., a multi-state cannabis organization that owns and manages cannabis facilities, as well as many leading branded products, Fireman has grown MariMed from its early stages to a publicly-traded company. MariMed was recently named The Best Performing Marijuana Stock in 2018 by Fresh Toast, one of the 3 Best Cannabis Stocks of 2018 by Motley Fool, and one of five Top Cannabis Stocks to Watch by High Times. MariMed has developed and manages six facilities in five states, has five additional facilities under development, distributes its branded products in seven states, and boasts a market cap of approximately $900 million (US).
Fireman will present an overview of MariMed’s current operations, examples of MariMed’s best-in-class branded products, an update of company strategy, and highlights of the company’s financial performance. His presentation will address MariMed’s competitive advantages in the US cannabis market, as well as a preview of emerging themes in the rapidly evolving U.S. cannabis industry.
The Canaccord Symposium brings together the best and brightest US cannabis entrepreneurs, institutional investors, venture funds, hedge funds, retail investors, family offices, and many industry experts. For more information, visit https://www.canaccordgenuity.com/capital-markets/about-us/events/US-Cannabis-Symposium/
Search MariMed and post on social media with the hash tag #MedicatedByMarimed:
Twitter: @MariMedInc
Facebook: @MariMedInc
Instagram: MariMedInc
YouTube: MariMedInc
# # #
About MariMed Inc.:
MariMed is a multi-state cannabis operator that develops, owns and manages cannabis facilities and branded product lines. MariMed’s team has developed state-of-the-art regulatory-compliant facilities in DE, IL, NV, MD, MA, and RI, which are models of excellence in horticultural principals, cannabis production, product development, and dispensary operations. In addition, MariMed is on the forefront of precision-dosed branded products for the treatment of specific medical conditions. MariMed currently distributes its branded products in approximately ten states, and is expanding licensing and distribution to additional markets, encompassing thousands of dispensaries. MariMed Inc. is one of the top-performing public cannabis companies in the U.S., according to the U.S. Marijuana Index, (www.marijuanaindex.com). For additional information, visit www.MariMedAdvisors.com
Forward Looking Statements:
This release contains certain forward-looking statements and information relating to MariMed Inc., that is based on the beliefs of MariMed Inc.’s management, as well as assumptions made by and information currently available to the Company. Such statements reflect the current views of the Company with respect to future events including estimates and projections about its business based on certain assumptions of its management, including those described in this Release. These statements are not guarantees of future performance and involve risk and uncertainties that are difficult to predict, including, among other factors, changes in demand for the Company's services and products, changes in the law and its enforcement and changes in the economic environment. Additional risk factors are included in the Company's public filings with the SEC. Should one or more of these underlying assumptions prove incorrect, actual results may vary materially from those described herein as "hoped," "anticipated," "believed," "planned, "estimated," "preparing," "potential," "expected" or words of a similar nature. The Company does not intend to update these forward-looking statements. None of the content of any of the websites referred to herein (even if a link is provided for your convenience) is incorporated into this release and the Company assumes no responsibility for any of such content.
Media Contacts: For MariMed Business Development Jon Levine, CFO, MariMed info@MariMedAdvisors.com 781-559-8713 Investor Relations Tyler Troup, Circadian Group tyler@circadian-group.com +1 (866) 950 8300 Media Relations Julie Shepherd, Accentuate PR Julie@accentuatepr.com 847-275-3643
Released October 17, 2018